Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Ascendis Pharma A/S

    NASDAQ: ASND · Real-Time Price · USD
    174.18
    1.08 (0.62%)
    At close: Jul 03, 2025, 2:42 PM
    174.32
    0.08%
    After-hours: Jul 03, 2025, 02:42 PM EDT
    0.62%
    Bid 165.28
    Market Cap 10.52B
    Revenue (ttm) 368.7M
    Net Income (ttm) -341.67M
    EPS (ttm) -6.66
    PE Ratio (ttm) -26.15
    Forward PE 85.06
    Analyst Buy
    Ask 182
    Volume 157,816
    Avg. Volume (20D) 495,475
    Open 172.86
    Previous Close 173.10
    Day's Range 169.81 - 174.39
    52-Week Range 111.09 - 183.00
    Beta 0.36

    About ASND

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol ASND
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for ASND stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    1 month ago
    +7.89%
    Ascendis Pharma shares are trading higher after th... Unlock content with Pro Subscription
    4 months ago
    +8.41%
    Ascendis Pharma shares are trading higher after Evercore ISI raised its price target on the stock from $220 to $260.
    news image

    1 month ago · accessnewswire.com

    Cerrado Gold and Ascendant Resources Announce Completion of Business Combination Transaction

    NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, ON / ACCESS Newswire / May 20, 2025 / Cerrado Gold Inc. ("Cerrado") (TSXV:CERT)(OTCQX:CRDOF) and Asce...

    news image

    2 months ago · seekingalpha.com

    Ascendis Pharma A/S (ASND) Q1 2025 Earnings Call Transcript

    Ascendis Pharma A/S (ASND) Q1 2025 Earnings Conference Call May 1, 2025 4:30 PM ET Company Participants Scott Smith - Executive Vice President and Chief Financial Officer Jan Mikkelsen - President and...

    news image

    2 months ago · zacks.com

    Are Medical Stocks Lagging Ascendis Pharma (ASND) This Year?

    Here is how Ascendis Pharma A/S (ASND) and Benitec Biopharma Limited (BNTC) have performed compared to their sector so far this year.

    news image

    2 months ago · seekingalpha.com

    Ascendis Pharma: Rare Disease Player Is A Buy On Yorvipath Launch Trajectory

    Shares of ASND have fared well during recent market volatility and the downturn in the biotech sector. Setbacks for competitors in PTH (hypoparathyroidism) paves the way for successful Yorvipath launc...

    news image

    2 months ago · accessnewswire.com

    Ascendant Resources Notifies Shareholders Of Upcoming Special Meeting

    TORONTO, ON / ACCESS Newswire / April 14, 2025 / Further to its press release on February 3, 2025, Ascendant Resources Inc. (the "Company" or "Ascendant") (TSX:ASND) announces that it has mailed and f...

    Add to Watchlist